Quisovalimab, CAS 2427667-03-4

Product Description: Quisovalimab (AVTX-002; AEVI 002; SAR 252067) is a human monoclonal antibody against LIGHT, a tumor necrosis factor (TNF)-related cytokine (TNFSF14) that plays an important role in acute respiratory distress syndrome (ARDS) and cytokine release syndrome (CRS) COVID-19. Quisovalimab can be used in COVID-19 acute respiratory distress syndrome and other studies[1].

Applications: Neuroscience-Neuromodulation

Formula: N/A

References: [1]David S Perlin, et al. Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS. mSphere. 2020 Aug 12;5(4):e00699-20.

CAS Number: 2427667-03-4

Molecular Weight: N/A

Compound Purity: 96.18

Research Area: Cardiovascular Disease

Solubility: 10 mM in DMSO

Target: SARS-CoV

• SKU: MEXHY-P99810-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99810-1
• Package Unit: 1 mg
• Quantity Unit: STK
• Conjugate: Unconjugated